Literature DB >> 19867369

C1q PRECIPITINS IN THE SERA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER HYPOCOMPLEMENTEMIC STATES: CHARACTERIZATION OF HIGH AND LOW MOLECULAR WEIGHT TYPES.

V Agnello1, D Koffler, J W Eisenberg, R J Winchester, H G Kunkel.   

Abstract

Precipitin reactions of C1q in gel diffusion proved useful in detecting unknown complexes containing gamma-globulin in the sera of patients with SLE. Using this method low molecular weight C1q reactants also have been detected in a number of sera from patients with SLE as well as other diseases. Both the circulating complexes and the unidentified low molecular weight reactants are associated with disease activity and in vivo complement depression. In some sera from patients with SLE, circulating complexes as detectable by C1q precipitation were closely associated with cryoprecipitins and an active nephritic process. Evidence is presented that both rheumatoid factors and C1q interact with circulating complexes in these patients and that the interaction is related to cryoprecipitation. The demonstration of the same rheumatoid factors in the cryoprecipitates and in the renal glomerular deposits suggests that rheumatoid factors have a special significance in the presence of circulating complexes.

Entities:  

Year:  1971        PMID: 19867369      PMCID: PMC2139071     

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Characteristics of immune complexes in connective tissue diseases.

Authors:  J S Davis; F E Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

Review 2.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 3.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

Review 4.  Mechanisms of immune deposit formation in renal glomeruli.

Authors:  M H Wener; M Mannik
Journal:  Springer Semin Immunopathol       Date:  1986

Review 5.  Pathological expression of idiotypic interactions: immune complexes and cryoglobulins.

Authors:  M Goldman; J C Renversez; P H Lambert
Journal:  Springer Semin Immunopathol       Date:  1983

Review 6.  Are anti-C1q antibodies different from other SLE autoantibodies?

Authors:  Matthew C Pickering; Marina Botto
Journal:  Nat Rev Rheumatol       Date:  2010-04-27       Impact factor: 20.543

7.  Studies of artificial cryoprecipitates containing anti-DNA antibody activity.

Authors:  R P Taylor; S J Waller; J S Davis; J B Winfield; K W Morley; E L Wright
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

Review 8.  Fundamental role of C1q in autoimmunity and inflammation.

Authors:  Myoungsun Son; Betty Diamond; Frances Santiago-Schwarz
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

9.  Anti-C1q in systemic lupus erythematosus.

Authors:  G Stojan; M Petri
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

Review 10.  The "other" vasculitis syndromes and kidney involvement.

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2009-11-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.